|
'Bioactive
Stents Are Safer Regarding Thrombosis'
The mid-term CSI PTCA registry reported the usage of 67,000
number of stents in India, of which Drug Eluting Stents(DES)
were 53 per cent in the year 2005. However, the use of DES
has come under the scanner after speakers at the World Congress
of Cardiology (WCC), Barcelona suggested that DES carries
a higher risk of potentially fatal blood clots than bare-metal
stents (BMS). Dr Ganesh Kumar, Interventional Cardiologist,
Dr L H Hiranandani Hospital, spoke to Rita Dutta about the
ripple effects of the controversy among Indian interventional
cardiologists.
|
